Inhibikase Therapeutics, Inc. - COM NEW (IKT)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM NEW
Number of holders
14
Total Shares
747K
Shares change
+664K
Total reported value, excl. options
$2.69M
Value change
+$2.39M
Put/Call ratio
0
Number of buys
13
Number of sells
-1
Price
$3.61
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.